Treated and untreated hypertension, hospitalization, and medical expenditure: An epidemiological study in 314 622 beneficiaries of the medical insurance system in Japan

Journal of Hypertension

Volumn 31, Issue 5, 2013, Pages 1032-1042

  Nakamura, Koshi ^a   Miura, Katsuyuki ^b   Nakagawa, Hideaki ^a   Okamura, Tomonori ^c   Okuda, Nagako ^d   Nishimura, Kunihiro ^e   Yasumura, Seiji ^f   Sakata, Kiyomi ^g   Hidaka, Hideki ^h   Okayama, Akira ⁱ  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^e National Cerebral and Cardiovascular Center   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

^h SANYO ELECTRIC CO LTD   (Japan)

ⁱ FUKUJUJI HOSPITAL   (Japan)

Author keywords

epidemiology; hospitalization; hypertension; medical expenditure; treatment

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84876285652     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835f5747     Document Type: Article

References (38)

1. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21:707-716.
2. Okayama A, Kadowaki T, Okamura T, Hayakawa T, Ueshima H, NIPPON DATA80 Research Group. Age-specific effects of systolic and diastolic blood pressures on mortality due to cardiovascular diseases among Japanese men (NIPPON DATA80). J Hypertens 2006; 24:459-462.
3. Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S. Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens 2009; 22:273-280.
4. O'Seaghdha CM, Perkovic V, Lam TH, McGinn S, Barzi F, Gu DF, et al. Asia Pacific Cohort Studies Collaboration. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension 2009; 54:509-515.
5. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 2003; 41:1341-1345.
6. Lawes CM, Vander Hoorn S, Rodgers A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
7. Hozawa A, Okamura T, Murakami Y, Kadowaki T, Okuda N, Takashima N, et al. NIPPON DATA80 Research Group. High blood pressure in middle age is associated with a future decline in activities of daily living. NIPPON DATA80. J Hum Hypertens 2009; 23:546-552.
8. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047.
9. Takahashi S, Okada K, Yanai M. The Kidney Early Evaluation Program (KEEP) of Japan: results from the initial screening period. Kidney Int 2010; Suppl:S17-S23.
10. Hebel JR, McCarter RJ, Sexton M. Healthcare costs for employed hypertensives. Med Care 1990; 28:446-457.
11. Kiiskinen U, Vartiainen E, Puska P, Aromaa A. Long-term cost and life-expectancy consequences of hypertension. J Hypertens 1998; 16:1103-1112.
12. Nakamura K, Okamura T, Kanda H, Hayakawa T, Kadowaki T, Okayama A, et al. Health Promotion Research Committee of the Shiga National Insurance Organizations. Impact of hypertension on medical economics: A 10-year follow-up study of national health insurance in Shiga, Japan. Hypertens Res 2005; 28:859-864.
13. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 2001; 20:233-241.
14. Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D. Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines. BMC Health Serv Res 2008; 8:161.
15. Wang G, Zhang Z, Ayala C. Hospitalization costs associated with hypertension as a secondary diagnosis among insured patients aged 18-64 years. Am J Hypertens 2010; 23:275-281.
16. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43:521-530.
17. Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care 2010; 48:418-425.
18. Health and Welfare Statistics Association. 2011/2012 Kokumin Eisei no Doko (Trend for National Health and Hygiene Japan) [in Japanese]. Tokyo: Health and Welfare Statistics Association; 2011.
19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187
20. Errata: J Hypertens 2007; 25:1749.
21. SHEP Cooperative Research Group. Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
22. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
23. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123:754-762.
24. Tanaka T, Okamura T, Yamagata Z, Takebayashi T, Tamura U, Kusaka Y, et al. HIPOP-OHP Research Group. Awareness and treatment of hypertension and hypercholesterolemia in Japanese workers: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Hypertens Res 2007; 30:921-928.
25. Ministry of Health, Labour and Welfare of Japan. An outline of the Japanese medical system. http://www.mhlw.go.jp/english/policy/health-medical/ health-insurance/index.html. [Accessed 1 August 2012].
26. Matsuda S, Ishikawa KB, Kuwabara K, Fujimori K, Fushimi K, Hashimoto H. Development and use of the Japanese case-mix system. Eurohealth 2008; 14:25-30.
27. Ministry of Health, Labour and Welfare of Japan. The basic guideline for health checkups and healthcare advice with a particular focus on the metabolic syndrome (final edition) [in Japanese]. Tokyo: Ministry of Health, Labour and Welfare of Japan; 2007.
28. Tanno K, Okamura T, Ohsawa M, Onoda T, Itai K, Sakata K, et al. Comparison of low-density lipoprotein cholesterol concentrations measured by a direct homogeneous assay and by the Friedewald formula in a large community population. Clin Chim Acta 2010; 411:1774-1780.
29. Masoudi FA, Foody JM, Havranek EP, Wang Y, Radford MJ, Allman RM, et al. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation 2006; 114:2806-2814.
30. Fang J, Alderman MH. Trend of stroke hospitalization, United States, 1988-1997. Stroke 2001; 32:2221-2226.
31. Moturu ST, Johnson WG, Liu H. Predictive risk modelling for forecasting high-cost patients: a real-world application using Medicaid data. Int J Biomed Eng Technol 2010; 3:114-132.
32. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14:32-38.
33. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
34. Murakami Y, Hozawa A, Okamura T, Ueshima H. Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Research Group (EPOCH-JAPAN). Relation of blood pressure and all-cause mortality in 180 000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension 2008; 51:1483-1491.
35. Chatellier G, Dutrey-Dupagne C, Vaur L, Zannad F, Genès N, Elkik F, et al. Home self blood pressure measurement in general practice. The SMART study. Self-measurement for the Assessment of the Response to Trandolapril. Am J Hypertens 1996; 9:644-652.
36. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, et al. Factors affecting the difference between screening and home blood pressure measurements: the Ohasama Study. J Hypertens 2001; 19: 13-19.
37. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: to 2003: the Akita-Osaka study. J Am Coll Cardiol 2008; 52:71-79.
38. Asayama K, Ohkubo T, Yoshida S, Suzuki K, Metoki H, Harada A, et al. Japan Arteriosclerosis Longitudinal Study (JALS) group. Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study. J Hypertens 2009; 27:357-364.